A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2011
10/19/2011	CN102218110A Four-medicine grinding soup concentrated pill and preparation method thereof
10/19/2011	CN102218109A Simotang chewable tablet and preparation method thereof
10/19/2011	CN102218108A Simotang honey pill and preparation method thereof
10/19/2011	CN102218106A Traditional Chinese medicine composition for treating deficiency of liver and kidney and preparation method thereof
10/19/2011	CN102218104A Traditional Chinese medicine preparation for preventing liver fibrosis and treating liver cirrhosis
10/19/2011	CN102218101A Medicine manufacturing technology and preparation method of Taisui capable of clearing kidney poison and raising vitality
10/19/2011	CN102218095A Processing method of myrobalan-processed kusnezoff monkshood root as mongolian medicine
10/19/2011	CN102218092A Dispersion tablets of traditional Chinese medicine composition
10/19/2011	CN102218090A Rice roasting processing method of traditional Chinese medicine salvia miltiorrhiza bunge
10/19/2011	CN102218088A Oral ulcer inunction liquid
10/19/2011	CN102218085A Quality control method for leaves of lithocarpus litseifolius(Hance)Chun as medicinal material
10/19/2011	CN102218078A Rifaximin suspension containing montmorillonite and preparation method thereof
10/19/2011	CN102218075A Composition for down-regulating pro-inflammatory markers
10/19/2011	CN102218073A Application of Esculentoside A in preparing drugs for controlling hepatic fibrosis or cirrhosis
10/19/2011	CN102218072A Pharmaceutical composition for treating calcium deficiency, and preparation thereof
10/19/2011	CN102218065A New application of aloperin in pharmacy
10/19/2011	CN102218061A Application of penehyclidine hydrochloride in preparation of medicine for treating motion sickness
10/19/2011	CN102218058A Application of sparstolenin B as TLR2 (Toll-like receptor 2)/TLR4 (Toll-like receptor 4) antagonist in pharmacy
10/19/2011	CN102218056A Use of butenolide I in preparing drugs for controlling immunological liver injury
10/19/2011	CN102218041A Ebastine solid dispersion and high-dissolubility ebastine tablet prepared by the same
10/19/2011	CN102218036A Formula, preparation method and application of omeprazole sodium liposome composite medicament
10/19/2011	CN102218035A Formula of combined medicament of esomeprazole sodium liposomes, method for preparing same and application thereof
10/19/2011	CN102218032A Formula, preparation method and application of lansoprazole liposome composite medicament
10/19/2011	CN102218030A Formula, preparation method and application of pantoprazole sodium liposome composite medicament
10/19/2011	CN102218021A Toothpaste for removing halitosis and preventing canker sore
10/19/2011	CN102217881A Liver-protecting and liver-benefiting health-care pillow
10/19/2011	CN102217757A Plant superoxide dismutase buccal tablets and preparation method thereof
10/19/2011	CN101940651B Traditional Chinese medicine superfine powder for preventing and treating chicken colibacillosis and preparation method thereof
10/19/2011	CN101904949B Plant extract liquor and preparation method thereof
10/19/2011	CN101838250B New application of thio-taxane derivatives
10/19/2011	CN101757014B Medicament for treating periodontal disease
10/19/2011	CN101721405B Application of diacetylbaicalein in preparation of drugs used for curing or preventing liver diseases
10/19/2011	CN101579375B Extract of bupleurum, preparation method and application thereof
10/19/2011	CN101480491B Bone collagen polypeptide composite solution for regulating intestines and preparation method thereof
10/19/2011	CN101268073B Heterocyclic compound, and production process and use thereof
10/18/2011	US8039488 Methods and compositions for inhibition of angiogenesis
10/18/2011	US8039482 Composition of solifenacin or salt thereof for use in solid formulation
10/18/2011	US8039464 Muscarinic antagonists with PARP and SIR modulating activity as agents for inflammatory diseases
10/18/2011	US8039460 CGRP receptor antagonists
10/18/2011	US8039006 Solid composition containing bacillus-type non-pathogenic bacterial spores
10/18/2011	CA2579207C Morpholine compound
10/18/2011	CA2561800C Anti-gluten egg yolk antibodies for the treatment of celiac disease
10/18/2011	CA2494557C Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
10/18/2011	CA2484038C Estrogen receptor modulators
10/18/2011	CA2478813C Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/18/2011	CA2475312C N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
10/18/2011	CA2466906C Pharmaceutical composition comprising a prostaglandin e1
10/18/2011	CA2440644C Inhibitors of integrin .alpha.v.beta.6
10/18/2011	CA2398018C Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/18/2011	CA2337328C Biocompatible polymers, preparation method and compositions containing same
10/13/2011	WO2011127302A2 Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
10/13/2011	WO2011126853A2 Prevention or delay of onset of oral mucositis
10/13/2011	WO2011126537A2 Oral adhering compositions that apply rhizophora mangle extract in the mouth
10/13/2011	WO2011125930A1 Prophylactic or therapeutic agent for inflammatory bowel diseases or autoimmune peripheral neuropathy
10/13/2011	WO2011125619A1 Intestinal protectant
10/13/2011	WO2011124430A1 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it
10/13/2011	WO2011123997A1 Traditional chinese medicine composition for treating gastric ulcer and preparation method thereof
10/13/2011	WO2011123996A1 Traditional chinese medicinal composition for curing duodenal ulcer and preparation method thereof
10/13/2011	WO2011123943A1 Methods for treating disorders of the gastrointestinal tract using a glp-1 agonist
10/13/2011	WO2011072216A9 Treatment methods utilizing stem cell mobilizers and immunosuppressive agents
10/13/2011	WO2011046395A3 Preventing or treating periodontal diseases by herbal extract
10/13/2011	WO2011037411A3 Composition comprising s-allyl-l-cysteine as active ingredient for preventing or treating gastrointestinal disorders
10/13/2011	US20110251290 Treatment of hepatic encephalopathy and liver cirrhosis
10/13/2011	US20110251286 Crystalline salts and/or co-crystals of O-desmethyltramadol
10/13/2011	US20110251274 Natural Vitamin E Compositions with Superior Antioxidant Potency
10/13/2011	US20110251254 Novel salt of tegaserod
10/13/2011	US20110251253 Solid forms of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide
10/13/2011	US20110251233 Formulation for the buccal transmucosal administration of setrons
10/13/2011	US20110251226 Cyclohexylamin isoquinolone derivatives
10/13/2011	US20110251220 Pharmaceutical compositions comprising gamma secretase modulators
10/13/2011	US20110251217 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
10/13/2011	US20110251183 Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
10/13/2011	US20110251180 Pharmaceutical agent comprising quinolone compound
10/13/2011	US20110251171 Heterocyclic compounds and methods of use
10/13/2011	US20110251156 Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
10/13/2011	US20110251144 Molecular modulators of the wnt/beta-catenin pathway
10/13/2011	US20110251139 Treatment of inflammatory bowel diseases with mammal beta defensins
10/13/2011	US20110251138 Lipoic acid metabolite conjugate: preparation and their therapeutic effect
10/13/2011	US20110251126 Intestinal treatment
10/13/2011	US20110250693 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
10/13/2011	US20110250299 Organogel compositions and processes for producing
10/13/2011	US20110250298 Composition to help protect a user against liver damage from alcohol consumption
10/13/2011	US20110250297 Treatment of Hyperproliferative Disorders Using Cardiac Glycosides
10/13/2011	US20110250291 Use of arsenic for cancer therapy protection
10/13/2011	US20110250278 Particles containing an opioid receptor antagonist and methods of use
10/13/2011	US20110250268 Compositions and Methods for Inhibiting Gastric Acid Secretion
10/13/2011	US20110250261 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
10/13/2011	US20110250238 System for the colon delivery of drugs subject to enzyme degradation and/or poorly absorbed in the gastrointestinal tract
10/13/2011	US20110250231 Method of using punicic acid to enhance immune response and prevent metabolic disorders
10/13/2011	US20110250228 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
10/13/2011	US20110250206 Markers for determination of patient responsiveness
10/13/2011	US20110250201 Antagonists of il-6 to raise albumin and/or lower crp
10/13/2011	US20110250200 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling
10/13/2011	US20110250195 Antibodies Against IL-25
10/13/2011	US20110250193 Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease
10/13/2011	US20110250190 Pharmaceutical preparation
10/13/2011	US20110250130 Tnf-alpha binding proteins
10/13/2011	CA2794849A1 Methods and compositions for the treatment of irritable bowel syndrome
10/13/2011	CA2788762A1 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it
10/12/2011	EP2374796A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders

1 ... 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 ... 1258